Evidence map›Paper›PMID 26596859›Full record

ArticleBrain research2016

Targeting the nNOS/peroxynitrite/calpain system to confer neuroprotection and aid functional recovery in a mouse model of TBI.

Mushfiquddin Khan, Tajinder S Dhammu, Fumiyo Matsuda, Balasubramaniam Annamalai, Tejbir Singh Dhindsa, Inderjit Singh, Avtar K Singh

Open access · greenAbstract read
In one paragraph

Article in Brain research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Asymmetric dimethylarginine exacerbates cognitive dysfunction associated with cerebrovascular pathology.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  11. Antioxidant Therapies in Traumatic Brain Injury.Antioxidants (Basel, Switzerland) · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Mushfiquddin KhanDepartment of Pediatrics, Medical University of South Carolina, Charleston, SC, United States.. Electronic address: khanm@musc.edu.
Tajinder S DhammuDepartment of Pediatrics, Medical University of South Carolina, Charleston, SC, United States.. Electronic address: dhammu@musc.edu.
Fumiyo MatsudaDepartment of Pediatrics, Medical University of South Carolina, Charleston, SC, United States.; School of Health Science, Kagoshima University, Kagoshima, Japan. Electronic address: fumiyo@health.nop.kagoshima-u.ac.jp.
Balasubramaniam AnnamalaiDepartment of Pediatrics, Medical University of South Carolina, Charleston, SC, United States.. Electronic address: annamal@musc.edu.
Tejbir Singh DhindsaDepartment of Pediatrics, Medical University of South Carolina, Charleston, SC, United States.. Electronic address: dhindsat@musc.edu.
Inderjit SinghDepartment of Pediatrics, Medical University of South Carolina, Charleston, SC, United States.. Electronic address: singhi@musc.edu.
Avtar K SinghDepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, United States; Ralph H. Johnson VA Medical Center, Charleston, SC, United States. Electronic address: singha@musc.edu.
Medical University of South Carolina · USKagoshima University · JP

Funding

EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR018823 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND, JOHN R · 2003 to 2003
$2.9M
MUSC FACIL EXPANSION &RENOV: SLE C06RR015455 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND, JOHN R · 2002 to 2002
$2.0M
Nitrosylation Mechanisms for Protection Against Neurovascular Inflammatory InjuryR01NS072511 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI SINGH, AVTAR K · 2011 to 2015
$1.6M
Development of S-Nitrosothiol-based Therapy for Alzheimer's DiseaseI01BX001062 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI SINGH, AVTAR K · 2011 to 2014
–
Immunomodulation and Neuroprotection in Multiple SclerosisI01BX002829 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI SINGH, INDERJIT · 2015 to 2025
–
BLRD VA I01 BX001062BLRD VA I01 BX002829NCRR NIH HHS C06 RR015455NCRR NIH HHS C06 RR018823NCRR NIH HHS C06RR018823NINDS NIH HHS NS-72511NINDS NIH HHS R01 NS072511
6 · The paper itself

Abstract

Traumatic brain injury (TBI) derails nitric oxide (NO)-based anti-inflammatory and anti-excitotoxicity mechanisms. NO is consumed by superoxide to form peroxynitrite, leading to decreased NO bioavailability for S-nitrosoglutathione (GSNO) synthesis and regulation of neuroprotective pathways. Neuronal peroxynitrite is implicated in neuronal loss and functional deficits following TBI. Using a contusion mouse model of TBI, we investigated mechanisms for the opposed roles of GSNO versus peroxynitrite for neuroprotection and functional recovery. TBI was induced by controlled cortical impact (CCI) in adult male mice. GSNO treatment at 2h after CCI decreased the expression levels of phospho neuronal nitric oxide synthase (pnNOS), alpha II spectrin degraded products, and 3-NT, while also decreasing the activities of nNOS and calpains. Treatment of TBI with FeTPPS, a peroxynitrite scavenger, had effects similar to GSNO treatment. GSNO treatment of TBI also reduced neuronal degeneration and improved neurobehavioral function in a two-week TBI study. In a cell free system, SIN-1 (a peroxynitrite donor and 3-nitrotyrosinating agent) increased whereas GSNO (an S-nitrosylating agent) decreased calpain activity, and these activities were reversed by, respectively, FeTPPS and mercuric chloride, a cysteine-NO bond cleaving agent. These data indicate that peroxynitrite-mediated activation and GSNO-mediated inhibition of the deleterious nNOS/calpain system play critical roles in the pathobiology of neuronal protection and functional recovery in TBI disease. Given GSNO׳s safety record in other diseases, its neuroprotective efficacy and promotion of functional recovery in this TBI study make low-dose GSNO a potential candidate for preclinical evaluation.

Indexed as

AnimalsBrainBrain InjuriesCalpainDisease Models, AnimalMaleMice, Inbred C57BLMotor ActivityNeuronsNeuroprotective AgentsNitric Oxide Synthase Type IPeroxynitrous AcidPhosphorylationRandom AllocationRecovery of FunctionS-NitrosoglutathioneCalpainCapn1 protein, mouseNeuroprotective AgentsNitric Oxide Synthase Type INos1 protein, mousePeroxynitrous AcidS-NitrosoglutathioneCalpainGSNONeurodegenerationnNOSPeroxynitriteTBI

Identifiers

PMID26596859
PMCPMC4684819
OpenAlexW2175688109

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.